Limberg's Flap is Recommended Option for Primary and Recurrent Surgery of Natal Cleft Pilonidal Disease

Abstract

This study was designed to evaluate the Limberg's flap for primary and recurrent surgery of natal cleft pilonidal disease. This research comprised 60 people who had pilonidal sinus surgery between January 2021 and December 2022. Local ethics committee permission and individual patient informed consent papers were acquired. Participants were split into two groups, each group contains 30 persons, one receiving excision and primary closure (group I) and the other receiving a Limberg flap (group II). Retrospective analysis of patient medical records. Telephone calls were made to the patients. The surgical procedures were compared in terms of operating time, postop pain relief, ease of using the restroom, and speed with which patients could return to work. Patients who had had pilonidal sinus surgery before, experienced a recurrence, could not be contacted, or were treated with other surgical approaches were not included in the analysis. We used a scale from 1 (extremely unsatisfactory) to 3 (very satisfied) to gauge how satisfied our patients were with our services. The average age of the 60 research participants was 26.6. There were five men for every one woman (84.3%). There were 32 patients in Group 1, or 53.3%, and 28 in Group 2, or 46.7%. Group 1 was followed for a mean of 57 9.4 months, whereas group 2 was followed for a mean of 35.7 8.3 months. Group 1 had a mean age of 26.3 2.4 years, whereas group 2 had a mean age of 27.1 1.6 years; this age difference was not statistically significant (P = 0.43). Group 1 had an average operating duration of 29.7 4.2 minutes, whereas group 2 averaged 59.1 6.8 minutes (P 0.001). There was no statistically significant difference between the two groups for the average length of hospital stay (3.3 0.2 vs 2.1 0.8 days; P = 0.649). There was no statistically significant difference between the two groups in terms of the incidence of minor complications including wound site infection, seroma, and wound opening (16.7% in group 1 and 15.9% in group 2) (P = 1.000). The recurrence rate was 9.7% in group 1 and 7.2% in group 2. However, the difference between the two groups in terms of recurrence rate was not statistically significant (P = 1.000).